Proteome Sciences Share Discussion Threads

[chutes01] 30/8/2023 00:47

New Tech
Onwards ££

[powderhound3] 29/8/2023 19:47

... and back it comes!
up 20% today on £70k shares traded...crazy!

The market makers have no stock.
This share is illiquid (spelling?)

Results last week mean very little.

If PS's new tech/offering works, then millions will be made.

You pays yer money... etc

[wrighty41] 28/8/2023 10:56

Reaction to Friday’s results was absurd.
Interim statement reads well with plenty of technological improvements to continue to add organic growth in revenues/profits from current/enhanced portfolio of offerings. Combined with SD facility opening later in the year 2023B & in particular 2024 should see a step change in the fortunes of PRM.
6p-8p share price this year with 12p+ easily achievable next year IMO.
W41

[badger60] 27/8/2023 11:43

If you could recap all the crud that Diggle, JT, the WW2 pilot, Pearce and other lying PRM zealots spouted over the decades (GE buys PRM for 9 bn....huge cons losta classic).....so many got shafted, and thankfully so did Diggle.Pearce is just sucking the juice out of what's left and has been for years.

[peverill] 27/8/2023 10:07

Like Jeffian says, we are here to make money,nothing more,it's not some medical crusade we invested in,it was to make money,for which the investment has been woeful despite the ramblings of PRM and many on here.Like I say,if PRM can't get it right,why do nobody's on a free bb think they can predict the future.25 years these have been chasing rainbows,and still nowhere near a blockbuster product.

[wasjobber] 27/8/2023 09:54

So, with no understanding of what PRM are doing, you basically don't like them.

That explains why you post negative nonsense all the time.

[peverill] 27/8/2023 09:51

Not a clue about the technology,but plenty about the BS this shower put out year in year out.The business has not moved forward in years,just enough to keep their head above water,hence the reason the loan was repaid,even Diggle ain't confident of future revenues and wanted repaying.It suits CJP down to the ground keeping it down here,hence why he should take it private and stop shafting shareholders year in year out.

[wasjobber] 27/8/2023 09:36

Do you have any knowledge of the technology? You should try reading their RNS properly with some understanding of the consequences of the new reagents and commercialisation PRM have just announced: -

"Sales of tags remained level during the period at £1.45m (H1 2022: £1.45m). We are seeing some volatility in the market with label-free methods but this is anticipated to be offset by growth in the number and value of commercial sub-licensees using TMT®/TMTproTM products in their commercial services."

The label-free methods they refer to are mostly DIA methods, where plexing was next to impossible. PRM have just announced the first reagent for plexing DIA measurements (6-plex), so now PRM will also be eating into this additional DIA market segment.

Therefore, with the commercial licensing of their TMT / TMT Pro and their new plexDIA reagents there will be significant growth.

[peverill] 27/8/2023 08:09

They never mentioned the 20% price decline before,so how do they make that up.Nothing here changes from year to year,revenues are flat and not covering the increases in costs end of.Every year the reports are the same,always something showing up in the4th quarter,but it never does,The business has flatlined and has for a few years.It owes CJP £10m which will never be repaid,like I said before,CJP needs to take it private,and stop having shareholders trousers down.And what Mrs S done for the business,SFA,despite her nice salary,it hasn't moved anywhere since she took over.

[wasjobber] 26/8/2023 22:23

It's a small blip, as PRM tried to explain. Mass spec proteomics is all about throughput and the new products mentioned yesterday will greatly increase sales (as i think pools2 was trying to explain). I'm reliably told, that the industry has been patiently waiting for the new 32-plex TMT Pro and the Isotopic 6-plex DIA reagents. Investors need to understand that increased throughput is paramount for mass spec proteomics and no other manufacturer comes close to what PRM offers with their growing range of multiplexing reagents. I believe most, if not all providers will eventually use them, as the benefits are huge.

[jeffian] 26/8/2023 22:11

So why are revenues, margins and profits declining?

This is an investment board, not The Lancet.

[wasjobber] 26/8/2023 21:58

Oh please, enlighten everyone. Whose multiplexing reagents are used more than Proteome Sciences for mass spec protein measurements?

[james japp] 26/8/2023 20:59

I think even goatherd himself would take issue with that last statement tbh, but I take your point.

[peverill] 26/8/2023 18:48

Pools,give it a rest,and stop misleading people,you haven't a clue what is going on here,PRM don't,so how the hell can you.You have a worse record than goatherd for the guessing game.

[pools2] 26/8/2023 12:14

The US laboratory expansion is a new facility in San Diego to perform "biomarker services" for the US market. As Proteome Sciences expands, they currently have two laboratories, one in Frankfurt, Germany and one in San Diego, USA.

I understand both laboratories are going to be very busy, as new much larger service contracts are being signed. Particularly, but not exclusively, for SysQuant SCP (Single Cell Proteomics), where PRM dominates the reagents for these important new workflows.

[palfrey man] 25/8/2023 20:58

Admit it everyone, PS is a lost cause lifestyle bag of manure and always has been.

[wasjobber] 25/8/2023 19:37

Time to BUY

[pools2] 25/8/2023 19:19

bluesky1st,

I couldn't agree more, absolute ridiculous overreaction.

There is some very positive news for the mass spec industry that's crying out for reagents that provide higher throughput. PRM provided that this morning in their RNS.

Isotopic 6-plex and isobaric 32-plex is a massive boast for the industry. Including the SysQuant SCP workflow release and the San Diego laboratory opening all providing a significant step change in revenue.

[bluesky1st] 25/8/2023 17:39

Massive overreaction there. Results not that bad. MM's definitely have some stock now... :)

[elpirata] 25/8/2023 15:41

gonefishing.gif

[monte1] 25/8/2023 15:19

Indeed peverill - the annual clutching at straws ritual has recommenced. We did hope that we had seen the back of that but sadly not.

[peverill] 25/8/2023 15:16

I see the clever board scratching around trying to make a silk purse out of this dirge.Read the last 19 annual reports,always something coming to cover the actual company performance.